MEET US 2026
ICGT Congress: Gentilly, FR | 27-28 May 2026
|
Simposio AFI: Rimini, IT | 10-12 Jun 2026
|
Antibody Industrial Symposium: Montpellier, FR | 30 Jun – 01 Jul 2026
|
Advanced Therapies Europe: Barcelona, ES | 07-09 Sep 2026
|
Bioproduction Congress: Lyon, FR | 22-23 Sep 2026
|
FarmaForum: Madrid, ES | 22-23 Sep 2026
|
BioSpain: Bilbao, ES | 29 Sep – 01 Oct 2026
|
CPHI 2026: Milan, IT | 06-08 Oct 2026
|
QC PharmaDay: Milan, IT | 15 Oct 2026
|
I4ID Mabdesign: Lyon, FR | 22-23 Oct 2026
|
BIO-Europe: Cologne, DE | 09-11 Nov 2026
|
European Bioanalysis Forum: Barcelona, ES | 17-19 Nov 2026
|
PharmaLab: Darmstadt, DE | 23-25 Nov 2026

Bioanalysis

All about bioanalysis

We explore the techniques, methods and advances regarding bioanalysis of small molecules, biologics and nucleic acids to improve patient health

Biodistribution and Shedding Studies for ATMPs and Gene Therapies: A Practical FAQ

Advanced Therapy Medicinal Products (ATMPs), viral vectors, and other emerging [...]

By |2026-05-25T14:01:05+02:0025. May 2026|Bioanalysis|Comments Off on Biodistribution and Shedding Studies for ATMPs and Gene Therapies: A Practical FAQ

Cannabinoid Bioanalysis: A Validated Multi-Analyte LC-MS/MS Method in Human Plasma

The growing interest in cannabinoid-based therapies has led to [...]

By |2026-04-27T13:49:51+02:0027. April 2026|Allgemein, Bioanalysis|Comments Off on Cannabinoid Bioanalysis: A Validated Multi-Analyte LC-MS/MS Method in Human Plasma

One-Stop-Shop solutions for Preclinical, Animal Health, Bioequivalence, and Clinical Studies

Developing new medicines or demonstrating the equivalence of generic products [...]

By |2026-03-19T13:32:14+01:0019. March 2026|Bioanalysis|Comments Off on One-Stop-Shop solutions for Preclinical, Animal Health, Bioequivalence, and Clinical Studies

Biosimilar Development: From Phase III to Analytical Comparability and PK/PD

Although the development of biosimilars has historically been difficult, [...]

By |2026-03-17T15:48:27+01:007. November 2025|Bioanalysis, CMC|Comments Off on Biosimilar Development: From Phase III to Analytical Comparability and PK/PD

ICH M10 Comparison with EMA and FDA Past Guidelines on Bioanalytical Method Validation

Although the ICH has published recommendations for the validation of [...]

By |2024-09-04T14:20:34+02:004. September 2024|Bioanalysis|Comments Off on ICH M10 Comparison with EMA and FDA Past Guidelines on Bioanalytical Method Validation
Go to Top